2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Hou, W; Quan, B; Wu, Q; Yang, J; Zhu, L | 1 |
1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Liver Neoplasms
| Article | Year |
|---|---|
Autophagy inhibition by reversine and its suppressive effects on human hepatocellular carcinoma cells.
Topics: Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Hep G2 Cells; Humans; Liver Neoplasms; Morpholines; Polyploidy; Purines; Tumor Stem Cell Assay | 2020 |